Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

NCT07027072 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment (MCI)
Mild Dementia
Alzheimer's Disease

Interventions

DRUG: KDS2010
DRUG: Placebo

Sponsor

NeuroBiogen Co., Ltd